StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
49
Publishing Date
2023 - 10 - 31
1
2023 - 09 - 19
1
2023 - 09 - 13
1
2023 - 09 - 05
1
2023 - 08 - 14
1
2023 - 07 - 13
1
2023 - 05 - 18
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 04 - 26
1
2023 - 04 - 12
1
2023 - 04 - 04
1
2023 - 03 - 31
1
2023 - 02 - 02
1
2022 - 12 - 13
1
2022 - 12 - 07
1
2022 - 10 - 13
1
2022 - 10 - 11
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 08
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 06 - 27
1
2022 - 06 - 08
1
2022 - 04 - 27
1
2022 - 04 - 22
1
2022 - 04 - 19
1
2022 - 03 - 25
1
2022 - 03 - 11
1
2022 - 02 - 28
1
2022 - 02 - 25
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 01 - 18
1
2021 - 12 - 21
1
2021 - 12 - 16
1
2021 - 12 - 13
2
2021 - 12 - 06
1
2021 - 11 - 29
1
2021 - 09 - 21
1
2021 - 09 - 16
1
2021 - 08 - 06
1
2021 - 07 - 23
1
2021 - 07 - 20
1
2021 - 07 - 19
1
2021 - 05 - 11
1
2021 - 04 - 08
1
Sector
Finance
1
Health technology
30
Manufacturing
7
Mining, quarrying, and oil and gas extraction
1
N/a
1
Professional, scientific, and technical services
2
Transportation and warehousing
1
Tags
Biopharma
51
Bioscience
39
Biotech
47
Biotech-bay
54
Biotech-beach
50
Biotechnology
49
Cancer
294
Cell
45
Children
40
Chmp
175
Clinical-trials-phase-ii
162
Clinical-trials-phase-iii
138
Conference
43
Covid
105
Covid-19
91
Disease
180
Drug
80
Europe
59
Events
47
Fda
104
Financial
45
Genetown
67
Global
63
Growth
110
Her2
50
Her2-
44
Liver
44
Market
92
Meeting
133
N/a
2325
Nasdaq
98
Ongoing
89
Pharm-country
75
Pharma
58
Pharmaceuticals
84
Phase 1
212
Phase 1b
49
Phase 2
273
Phase 2b
108
Phase 3
220
Positive
3027
Positive results
93
Potential
68
Pre-clinical
79
Preclinical
120
Presentation
46
Program
51
Report
59
Research
289
Results
874
Study
338
Technology
51
Test
57
Therapeutics
306
Therapy
185
Topline
352
Treatment
442
Trial
767
Update
50
Vaccine
105
Entities
Adaptimmune therapeutics plc
1
Adicet bio, inc.
1
Allogene therapeutics, inc.
2
Alzamend neuro inc
1
American international group, inc.
1
Anaptysbio, inc.
1
Astellas pharma inc
1
Athersys, inc.
1
Beigene, ltd.
1
Capricor therapeutics, inc.
1
Cellectis s.a.
1
Celularity inc - class a
4
Creative medical technology holdings, inc.
3
Cytodyn inc.
1
Design therapeutics inc
1
Dynavax technologies corporation
1
Enanta pharmaceuticals, inc.
1
Humacyte inc
1
Immunocore holdings plc - adr
1
Immutep limited
1
Inovio pharmaceuticals, inc.
3
Johnson & johnson
1
Kezar life sciences, inc.
1
Lantern pharma inc.
1
Larimar therapeutics, inc.
1
Legend biotech corporation
1
Moderna, inc.
1
Novavax, inc.
1
Nuvalent inc - class a
1
Pharmacyte biotech inc
3
Portage biotech inc
1
Sanofi
1
Scynexis, inc.
4
Seagen inc.
1
Skye bioscience, inc.
1
Tiziana life sciences plc
2
Windtree therapeutics, inc.
1
Symbols
ACET
1
ADAP
1
AIG
1
ALLO
2
ALPMF
1
ALPMY
1
ALZN
1
ANAB
1
ATHX
1
BEIGF
1
BGNE
1
CAPR
1
CELU
4
CELZ
3
CLLS
1
CYDY
1
DSGN
1
DVAX
1
ENTA
1
HUMA
1
IMCR
1
IMMP
1
INO
3
JNJ
1
KZR
1
LEGN
1
LRMR
1
LTRN
1
MRNA
1
NUVL
1
NVAX
1
PMCB
3
PRTG
1
SCYX
4
SGEN
1
SKYE
1
SNY
1
SNYNF
1
TLSA
2
WINT
1
Exchanges
Nasdaq
47
Nyse
2
Crawled Date
2023 - 10 - 31
1
2023 - 09 - 19
1
2023 - 09 - 13
1
2023 - 09 - 05
1
2023 - 08 - 14
1
2023 - 07 - 13
1
2023 - 05 - 18
1
2023 - 05 - 09
1
2023 - 05 - 08
1
2023 - 04 - 26
1
2023 - 04 - 12
1
2023 - 04 - 04
1
2023 - 03 - 31
1
2023 - 02 - 02
1
2022 - 12 - 13
1
2022 - 12 - 07
1
2022 - 10 - 13
1
2022 - 10 - 11
1
2022 - 09 - 28
1
2022 - 09 - 26
1
2022 - 09 - 08
1
2022 - 07 - 27
1
2022 - 07 - 26
1
2022 - 06 - 27
1
2022 - 06 - 08
1
2022 - 04 - 27
1
2022 - 04 - 22
1
2022 - 04 - 19
1
2022 - 03 - 25
1
2022 - 03 - 11
1
2022 - 02 - 28
1
2022 - 02 - 25
1
2022 - 02 - 15
1
2022 - 02 - 10
1
2022 - 01 - 18
1
2021 - 12 - 21
1
2021 - 12 - 16
1
2021 - 12 - 13
2
2021 - 12 - 06
1
2021 - 11 - 29
1
2021 - 09 - 21
1
2021 - 09 - 16
1
2021 - 08 - 06
1
2021 - 07 - 23
1
2021 - 07 - 20
1
2021 - 07 - 19
1
2021 - 05 - 11
1
2021 - 04 - 08
1
Crawled Time
09:00
2
11:00
3
12:00
6
12:20
1
13:00
4
13:20
6
14:00
5
14:30
3
15:00
2
15:20
1
16:00
3
17:00
2
18:00
1
20:00
3
21:00
1
22:00
3
23:00
3
Source
www.biospace.com
49
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
positive
tags :
Biotechnology
save search
Adaptimmune Reports Positive Data with Lete-cel[1] from an Interim Analysis of the Pivotal IGNYTE-ESO Trial for People with Synovial Sarcoma or MRCLS
Published:
2023-10-31
(Crawled : 14:00)
- biospace.com/
ADAP
|
$0.9978
-3.13%
-3.23%
1.2M
|
Health Technology
|
85.59%
|
O:
2.7%
H:
2.23%
C:
-5.14%
positive
trial
BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA®
Published:
2023-09-19
(Crawled : 12:00)
- biospace.com/
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-35.83%
|
O:
0.16%
H:
1.03%
C:
-0.19%
tevimbra
europe
positive
global
Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease
Published:
2023-09-13
(Crawled : 12:00)
- biospace.com/
MRNA
|
News
S
|
$103.45
-0.33%
-0.33%
2M
|
Health Technology
|
-1.38%
|
O:
8.13%
H:
0.95%
C:
-4.58%
rare
disease
mrna
positive
results
Nuvalent Initiates the Phase 2 Portion of ARROS-1 Clinical Trial for Patients with ROS1-Positive NSCLC and other Solid Tumors
Published:
2023-09-05
(Crawled : 12:00)
- biospace.com/
NUVL
|
$64.19
-0.87%
-0.89%
590K
|
|
39.37%
|
O:
-0.06%
H:
3.79%
C:
3.04%
tumors
trial
FDA Approves J&J’s Akeega for BRCA-Positive Prostate Cancer
Published:
2023-08-14
(Crawled : 12:20)
- biospace.com/
JNJ
|
News
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-16.29%
|
O:
0.86%
H:
0.0%
C:
0.0%
fda
cancer
Skye Bioscience Receives Positive Safety Review for Final Cohort of Fully-Enrolled Phase 1 Study of SBI-100 Ophthalmic Emulsion
Published:
2023-07-13
(Crawled : 16:00)
- biospace.com/
SKYE
|
$9.17
-20.98%
27K
|
Transportation and Warehousing
|
76191.08%
|
O:
-6.1%
H:
6.5%
C:
4.5%
sbi-100
review
positive
bioscience
study
Creative Medical Technology Holdings Announces Positive Top-Line Study Results for Chronic Lower Back Pain Utilizing its StemSpine® Procedure Using AlloStem™ Allogenic Cell Line
Published:
2023-05-18
(Crawled : 22:00)
- biospace.com/
CELZ
|
$4.91
-5.58%
-5.91%
19K
|
|
-21.21%
|
O:
6.06%
H:
2.71%
C:
-15.41%
stemspine
back
positive
cell
medical
technology
results
study
Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses
Published:
2023-05-09
(Crawled : 12:00)
- biospace.com/
SNY
|
News
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-17.18%
|
O:
-0.58%
H:
0.0%
C:
0.0%
NVAX
|
$3.895
-2.38%
-2.44%
3.7M
|
Health Technology
|
-46.44%
|
O:
20.4%
H:
26.64%
C:
6.13%
covid
vaccine
positive
influenza
topline
results
show
Enanta Pharmaceuticals Reports Positive Topline Results from Phase 2 SPRINT Trial Evaluating EDP-235 in Standard Risk Patients with COVID-19
Published:
2023-05-08
(Crawled : 22:00)
- biospace.com/
ENTA
|
News
|
$14.005
-8.82%
-9.68%
190K
|
Health Technology
|
-57.36%
|
O:
0.06%
H:
0.0%
C:
-4.74%
edp-235
covid-19
positive
risk
pharmaceuticals
topline
trial
results
European Committee for Orphan Medicinal Products Provides Positive Opinion on INOVIO's Application for Orphan Drug Designation for INO-3107
Published:
2023-04-26
(Crawled : 13:20)
- biospace.com/
INO
2 d
|
$11.05
14.69%
12.81%
700K
|
Health Technology
|
1072.43%
|
O:
-0.18%
H:
2.4%
C:
-1.56%
ino-3107
drug
positive
designation
application
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Published:
2023-04-12
(Crawled : 18:00)
- biospace.com/
CELZ
|
$4.91
-5.58%
-5.91%
19K
|
|
7.44%
|
O:
160.33%
H:
5.56%
C:
-30.56%
positive
medical
technology
diabetes
results
study
Tiziana Announces Positive Data on Intranasal Anti-CD3 Monoclonal Antibody in Intracerebral Hemorrhage
Published:
2023-04-04
(Crawled : 17:00)
- biospace.com/
TLSA
|
$0.552
0.27%
0.27%
95K
|
Health Technology
|
-45.76%
|
O:
0.49%
H:
2.94%
C:
-21.56%
anti-cd3
antibody
positive
Immutep Announces Positive Final Data in 2nd Line Metastatic NSCLC Patients Refractory to Anti-PD-(L)1 Therapy at European Lung Cancer Congress 2023
Published:
2023-03-31
(Crawled : 17:00)
- biospace.com/
IMMP
|
News
|
$2.255
-0.22%
-0.22%
200K
|
Health Technology
|
31.4%
|
O:
2.91%
H:
0.56%
C:
-5.08%
lung
positive
cancer
therapy
INOVIO Reports Positive Phase 1b Results for INO-4201 as an Ebola Booster for rVSV-ZEBOV (Ervebo®)
Published:
2023-02-02
(Crawled : 14:00)
- biospace.com/
INO
2 d
|
$11.05
14.69%
12.81%
700K
|
Health Technology
|
476.95%
|
O:
2.99%
H:
8.72%
C:
4.07%
ino-4201
ervebo
ebola
positive
phase 2b
Cellectis Announces Positive Preliminary Clinical Data for UCART22 in ALL and UCART123 in AML
Published:
2022-12-13
(Crawled : 13:00)
- biospace.com/
CLLS
|
$2.48
-0.4%
-0.4%
6.9K
|
Health Technology
|
11.66%
|
O:
5.83%
H:
5.93%
C:
-0.85%
ucart22
aml
ucart123
positive
Design Therapeutics Reports Positive Data from Single-Ascending Dose Trial of DT-216 for the Treatment of Friedreich Ataxia and Portfolio Progress
Published:
2022-12-07
(Crawled : 23:00)
- biospace.com/
DSGN
|
$3.95
7.05%
6.58%
420K
|
Professional, Scientific, and T...
|
-72.67%
|
O:
-0.59%
H:
3.87%
C:
-5.44%
dt-216
treatment
trial
therapeutics
positive
friedreich’s ataxia
INOVIO Reports Positive Interim Phase 1/2 Results for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
Published:
2022-10-13
(Crawled : 13:20)
- biospace.com/
INO
2 d
|
$11.05
14.69%
12.81%
700K
|
Health Technology
|
491.1%
|
O:
-3.68%
H:
8.92%
C:
8.28%
ino-3107
treatment
respiratory
positive
phase 1
SCYNEXIS to Present Positive Interim Data from the Phase 3 FURI Study of Oral Ibrexafungerp at IDWeek 2022
Published:
2022-10-11
(Crawled : 13:20)
- biospace.com/
SCYX
|
$1.42
0.71%
0.7%
130K
|
Health Technology
|
-45.56%
|
O:
-0.39%
H:
12.4%
C:
4.26%
positive
study
Windtree Therapeutics Announces Positive Istaroxime Phase 2 Study in Early Cardiogenic Shock (SEISMiC) Published in the European Journal of Heart Failure
Published:
2022-09-28
(Crawled : 22:00)
- biospace.com/
WINT
|
News
|
$0.3903
-7.4%
-7.99%
110K
|
Health Technology
|
-97.3%
|
O:
2.37%
H:
5.62%
C:
0.09%
heart
therapeutics
positive
study
phase 2
Creative Medical Technology Announces Peer Reviewed Publication of Positive Results for StemSpine® Study
Published:
2022-09-26
(Crawled : 16:00)
- biospace.com/
CELZ
|
$4.91
-5.58%
-5.91%
19K
|
|
-5.04%
|
O:
-0.91%
H:
5.97%
C:
-10.62%
stemspine
technology
positive
publication
study
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
News
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
News
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.